華潤三九醫藥有限公司 - 收益表 (TTM)

華潤三九醫藥有限公司
CN ˙ SZSE ˙ CNE0000011K8
¥24.21 ↑0.28 (1.17%)
2026-06-05
分享價格
收益表 (TTM)

華潤三九醫藥有限公司收益表顯示了一段時間內收入和支出的變化。收益表的數據包括銷售和收入、毛利、研發開支(R&D)、銷售、一般及行政開支(SG&A)、營業利潤、所得稅開支、財務成本、非營業收益、每股盈利(EPS)和已發行股份。

除以每股為單位的數字外,所有數字為1,000,000倍數。

2021
06-30
2021
09-30
2022
01-01
2022
03-31
2022
06-30
2022
09-30
2023
01-01
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
收入 15,623 15,586 15,544 15,715 16,081 16,393 18,079 20,182 22,825 24,577 24,739 25,681 25,699 25,871 27,617 27,176 28,321 29,863 31,603 32,879
改變 (%) -0.24 -0.26 1.10 2.33 1.94 10.29 11.63 13.10 7.68 0.66 3.81 0.07 0.67 6.75 -1.59 4.21 5.44 5.83 4.04
佔收入的百分比 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
銷售成本 6,094 6,262 6,561 6,836 7,193 7,495 8,354 9,342 10,839 11,813 11,675 12,155 11,950 12,045 13,452 13,257 13,790 14,312 14,567 14,805
改變 (%) 2.76 4.76 4.19 5.22 4.21 11.46 11.83 16.02 8.99 -1.17 4.11 -1.68 0.79 11.68 -1.45 4.02 3.79 1.78 1.64
佔收入的百分比 39.01 40.18 42.21 43.50 44.73 45.72 46.21 46.29 47.49 48.07 47.19 47.33 46.50 46.56 48.71 48.78 48.69 47.93 46.09 45.03
營業毛利 9,529 9,323 8,984 8,879 8,888 8,898 9,725 10,839 11,986 12,764 13,064 13,526 13,748 13,826 14,164 13,919 14,531 15,550 17,036 18,074
改變 (%) -2.16 -3.64 -1.17 0.10 0.11 9.30 11.46 10.58 6.49 2.35 3.53 1.65 0.56 2.45 -1.73 4.39 7.02 9.55 6.09
佔收入的百分比 60.99 59.82 57.79 56.50 55.27 54.28 53.79 53.71 52.51 51.93 52.81 52.67 53.50 53.44 51.29 51.22 51.31 52.07 53.91 54.97
銷售、一般及行政費用 6,492 6,401 6,005 5,644 5,856 5,715 6,141 6,699 7,542 8,097 8,544 8,738 8,618 8,619 8,942 8,852 9,658 10,515 11,004 11,876
改變 (%) -1.40 -6.18 -6.01 3.75 -2.41 7.45 9.10 12.58 7.35 5.53 2.27 -1.37 0.01 3.75 -1.01 9.10 8.88 4.65 7.92
佔收入的百分比 41.55 41.07 38.63 35.92 36.42 34.86 33.97 33.20 33.04 32.94 34.54 34.03 33.54 33.32 32.38 32.57 34.10 35.21 34.82 36.12
研發 527 541 560 588 539 558 594 622 674 700 715 719 746 768 802 809 934 1,130 1,268 1,465
改變 (%) 2.70 3.48 4.91 -8.30 3.51 6.46 4.79 8.32 3.78 2.13 0.67 3.67 3.02 4.36 0.88 15.52 20.93 12.23 15.54
佔收入的百分比 3.37 3.47 3.60 3.74 3.35 3.40 3.29 3.08 2.95 2.85 2.89 2.80 2.90 2.97 2.90 2.98 3.30 3.78 4.01 4.46
營運支出 13,319 13,401 13,331 13,238 13,813 13,966 15,296 16,899 19,359 20,873 21,196 21,878 21,487 21,677 23,426 23,122 24,763 26,204 27,173 28,562
改變 (%) 0.61 -0.52 -0.69 4.34 1.11 9.52 10.48 14.55 7.82 1.55 3.22 -1.79 0.88 8.07 -1.30 7.10 5.82 3.70 5.11
佔收入的百分比 85.25 85.98 85.76 84.24 85.90 85.20 84.60 83.74 84.82 84.93 85.68 85.19 83.61 83.79 84.83 85.08 87.44 87.75 85.98 86.87
營業收入 2,304 2,185 2,214 2,476 2,268 2,427 2,784 3,282 3,466 3,704 3,543 3,803 4,212 4,194 4,191 4,055 3,558 3,659 4,430 4,316
改變 (%) -5.18 1.31 11.86 -8.41 6.99 14.71 17.91 5.59 6.87 -4.34 7.34 10.75 -0.41 -0.09 -3.25 -12.25 2.84 21.06 -2.56
佔收入的百分比 14.75 14.02 14.24 15.76 14.10 14.80 15.40 16.26 15.18 15.07 14.32 14.81 16.39 16.21 15.17 14.92 12.56 12.25 14.02 13.13
利息花費 -5 -11 -14 -16 -16 -19 -21 -27 -40 -59 -81 -92 -97 -94 -80 -81 -86 -96 -118 -128
改變 (%) 143.94 25.22 10.13 1.37 20.73 11.08 28.33 47.42 47.52 36.36 13.76 5.40 -3.00 -14.81 1.07 6.91 11.52 21.96 8.85
佔收入的百分比 -0.03 -0.07 -0.09 -0.10 -0.10 -0.12 -0.12 -0.13 -0.18 -0.24 -0.33 -0.36 -0.38 -0.36 -0.29 -0.30 -0.31 -0.32 -0.37 -0.39
淨利 1,919 1,773 2,055 2,253 2,112 2,251 2,449 2,759 2,893 2,899 2,853 3,066 3,374 3,410 3,368 3,274 2,785 2,761 3,421 3,227
改變 (%) -7.61 15.93 9.63 -6.24 6.58 8.77 12.67 4.85 0.21 -1.59 7.46 10.06 1.07 -1.24 -2.78 -14.95 -0.86 23.91 -5.68
佔收入的百分比 12.28 11.37 13.22 14.34 13.14 13.73 13.54 13.67 12.67 11.80 11.53 11.94 13.13 13.18 12.20 12.05 9.83 9.25 10.83 9.81

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista